SABS
SAB Biotherapeutics, Inc.
There isn't enough reported data to score SABS yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SABS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Unavailable | |
| Unavailable |
SABS's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SABS PE Valuation
SABS has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SABS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect SABS's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SABS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$3.09 | +$3.10 |
| Q2 2025 | -$4.00 | +$2.07 |
| Q1 2025 | -$3.70 | +$2.98 |
| Q4 2024 | -$3.68 | +$3.96 |
| Q3 2024 | -$6.19 | -$0.46 |
| Q2 2024 | -$6.07 | +$0.26 |
| Q1 2024 | -$6.68 | -$0.65 |
| Q4 2023 | -$7.64 | -$3.31 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 150% for SABS versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
SABS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $114.7K | -62% |
| Q2 2024 | $263.1K | +208% |
| Q1 2024 | $944.6K | +63% |
| Q4 2023 | $305K | -86% |
| Q3 2023 | $1.3M | -65% |
| Q2 2023 | $85.5K | -99% |
| Q1 2023 | $581.1K | -95% |
| Q4 2022 | $2.2M | -80% |
UNH has the stronger quarterly revenue trend. Revenue is down 62% for SABS versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -8726% | -2538 points |
| Q2 2024 | -3877% | +3696 points |
| Q1 2024 | -1206% | +68 points |
| Q4 2023 | -6188% | -5824 points |
| Q3 2023 | -420% | -203 points |
| Q2 2023 | -7573% | -7470 points |
| Q1 2023 | -1274% | -1217 points |
| Q4 2022 | -364% | -297 points |
SABS's operating margin was −8726% last quarter, down 8306 points from the same quarter a year ago, near the bottom of its range since 2021.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
SABS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$9.6M | +$3.9M |
| Q3 2024 | -$6.4M | -$1.1M |
| Q2 2024 | -$7.8M | -$2.8M |
| Q1 2024 | -$10.9M | -$9.3M |
| Q4 2023 | -$13.5M | -$11.8M |
| Q3 2023 | -$5.3M | +$3M |
| Q2 2023 | -$4.9M | +$900.1K |
| Q1 2023 | -$1.6M | +$10M |
UNH has the stronger cash trend. Its trailing FCF is up 5.2% versus its history, compared with SABS at down 97%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
SABS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +17% | +13.5M shares |
| 1 year | +903% | +83.9M shares |
| 3 years | +1750% | +88.2M shares |
| 5 years | +37195% | +93M shares |
SABS has 93M diluted shares, up 903% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over SABS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
SABS Net Leverage
SABS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SABS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.1 | Neutral |
| Stochastic | 46.0 | Neutral |
SABS's weekly RSI is 45 (neutral) and its Stochastic is 46 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SABS PE vs Healthcare Sector
| Metric | SABS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SABS has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SABS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 2.3% above |
| 20 week MA | $3.41 | 9.7% below |
| 50 week MA | $3.66 | 16% below |
| 100 week MA | $3.02 | 2% above |
| 200 week MA | $4.35 | 29% below |
SABS's trend is mixed: it's above two of its five weekly moving averages, and 29% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over SABS on trend strength, trading above more of its moving averages.
SABS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $102.1 | $87.5 | -14% |
| 2022 | $87.5 | $6.90 | -92% |
| 2023 | $6.90 | $6.88 | -0.3% |
| 2024 | $6.88 | $4.18 | -39% |
| 2025 | $4.18 | $3.78 | -9.6% |
| 2026 YTD | $3.78 | $3.08 | -19% |
SABS has finished every year since 2021 lower, and it's down 19% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over SABS on returns for 2026, with the stronger performance.